Literature DB >> 26689650

Tolerability and efficacy of rituximab-containing immunochemotherapy in patients with B-cell non-Hodgkin lymphoma receiving hemodialysis.

Yotaro Ochi1, Nobuhiro Hiramoto2, Yuichiro Ono1, Satoshi Yoshioka1, Sumie Tabata1, Noboru Yonetani1, Akiko Matsushita1, Yukihiro Imai3, Takayuki Ishikawa1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26689650     DOI: 10.3109/10428194.2015.1115033

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  2 in total

1.  Rituximab use for lymphoplasmacytic lymphoma during continuous renal replacement therapy.

Authors:  Marco Simões; Marisa Miranda; José Carda; Anália Carmo; Paulo Martins
Journal:  Rev Bras Ter Intensiva       Date:  2019-06-27

2.  Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.

Authors:  Hajime Yasuda; Mutsuko Yasuda; Norio Komatsu
Journal:  Cancer Sci       Date:  2021-06-11       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.